Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366996640> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4366996640 endingPage "588" @default.
- W4366996640 startingPage "585" @default.
- W4366996640 abstract "The treatment of chronic myeloid leukemia (CML) was revolutionized with the advent of the first-generation tyrosine kinase inhibitors (TKIs), but drug resistance developed during treatment, leading to the development of the second-generation (dasatinib, nilotinib, and bosutinib) and third-generation (ponatinib) TKI. Compared with previous treatment regimens, specific TKI can significantly improve the response rate, overall survival rate and prognosis of CML. Only a few patients with BCR-ABL mutation are insensitive to the second-generation TKIs, so it is suggested to select the second-generation TKIs for patients with specific mutations. For patients with other mutations and without mutations, the second-generation TKI should be selected according to the patient's medical history, while the third-generation TKIs should be selected for mutations that are insensitive to the second-generation TKIs, such as T315I mutation that is sensitive to ponatinib. Due to different BCR-ABL mutations in patients with different sensitivity to the second and third-generation TKIs, this paper will review the latest research progress of the efficacy of the second and third-generation TKIs in CML patients with BCR-ABL mutations.慢性髓性白血病BCR-ABL 突变与二、三代TKI的疗效研究进展.随着第一代酪氨酸激酶抑制剂（TKI）的问世，慢性髓性白血病的治疗发生了革命性变化，但在治疗过程中出现了耐药性，由此研发了第二代（达沙替尼、尼洛替尼和博苏替尼）和第三代（普纳替尼）TKI。相比之前的治疗方案，选择特定的TKI能显著提高慢性髓性白血病的缓解率、总生存率，改善预后，仅少数BCR-ABL 突变患者对二代TKI不敏感，建议针对有特定突变的患者选择二代TKI，对于其他突变和没有突变的患者，应根据患者的病史选择二代TKI，对二代TKI不敏感的突变可选择三代TKI，如T315I突变对第三代TKI普纳替尼敏感。由于不同BCR-ABL 突变的患者对二、三代TKI的敏感性不同，本文将对二、三代TKI在BCR-ABL 突变的慢性髓性白血病患者中疗效的最新研究进展作一综述。." @default.
- W4366996640 created "2023-04-27" @default.
- W4366996640 creator A5027967598 @default.
- W4366996640 creator A5072514692 @default.
- W4366996640 date "2023-04-01" @default.
- W4366996640 modified "2023-09-28" @default.
- W4366996640 title "[Research Advance of BCR-ABL Mutation and the Efficacy of Second and Third Generation TKI in Chronic Myeloid Leukemia--Review]." @default.
- W4366996640 doi "https://doi.org/10.19746/j.cnki.issn.1009-2137.2023.02.040" @default.
- W4366996640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37096538" @default.
- W4366996640 hasPublicationYear "2023" @default.
- W4366996640 type Work @default.
- W4366996640 citedByCount "0" @default.
- W4366996640 crossrefType "journal-article" @default.
- W4366996640 hasAuthorship W4366996640A5027967598 @default.
- W4366996640 hasAuthorship W4366996640A5072514692 @default.
- W4366996640 hasConcept C126322002 @default.
- W4366996640 hasConcept C170493617 @default.
- W4366996640 hasConcept C2777413986 @default.
- W4366996640 hasConcept C2777583451 @default.
- W4366996640 hasConcept C2778208673 @default.
- W4366996640 hasConcept C2778729363 @default.
- W4366996640 hasConcept C2779536868 @default.
- W4366996640 hasConcept C2780381907 @default.
- W4366996640 hasConcept C42362537 @default.
- W4366996640 hasConcept C502942594 @default.
- W4366996640 hasConcept C71924100 @default.
- W4366996640 hasConceptScore W4366996640C126322002 @default.
- W4366996640 hasConceptScore W4366996640C170493617 @default.
- W4366996640 hasConceptScore W4366996640C2777413986 @default.
- W4366996640 hasConceptScore W4366996640C2777583451 @default.
- W4366996640 hasConceptScore W4366996640C2778208673 @default.
- W4366996640 hasConceptScore W4366996640C2778729363 @default.
- W4366996640 hasConceptScore W4366996640C2779536868 @default.
- W4366996640 hasConceptScore W4366996640C2780381907 @default.
- W4366996640 hasConceptScore W4366996640C42362537 @default.
- W4366996640 hasConceptScore W4366996640C502942594 @default.
- W4366996640 hasConceptScore W4366996640C71924100 @default.
- W4366996640 hasIssue "2" @default.
- W4366996640 hasLocation W43669966401 @default.
- W4366996640 hasOpenAccess W4366996640 @default.
- W4366996640 hasPrimaryLocation W43669966401 @default.
- W4366996640 hasRelatedWork W1554937972 @default.
- W4366996640 hasRelatedWork W2155107050 @default.
- W4366996640 hasRelatedWork W2401908067 @default.
- W4366996640 hasRelatedWork W2782601539 @default.
- W4366996640 hasRelatedWork W2952141298 @default.
- W4366996640 hasRelatedWork W3109015917 @default.
- W4366996640 hasRelatedWork W3118230164 @default.
- W4366996640 hasRelatedWork W388027184 @default.
- W4366996640 hasRelatedWork W4282926721 @default.
- W4366996640 hasRelatedWork W4283524715 @default.
- W4366996640 hasVolume "31" @default.
- W4366996640 isParatext "false" @default.
- W4366996640 isRetracted "false" @default.
- W4366996640 workType "article" @default.